Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
Clinical trial NCT04890366 · UNKNOWN
Trial details
- NCT number
- NCT04890366
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.